MototsuguTanaka NiigataJapan

Wcn26 Post edited Speaker Card

29 March 2026

Time

Session

8:10 a.m.

9:10 a.m.

Industry Symposium 5

HiddoLambers Heerspink Moderator H.J.Lambers.Heerspink@umcg.nlNetherlands

NaokiKashihara Moderator kashinao@med.kawasaki-m.ac.jpJapan

Clinical Impacts and Importance of Minimizing Drug Approval Delay

NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan
HCE (hierarchical composite end points) and eGFR slope, as potential solutions to delays in approval

HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
Bridging Academia and Regulators in Kidney Drug Development: Insights from Japan

MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan
Panel Discussion

DustinLittle Moderator dustin.little@astrazeneca.comUnited States

HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands

MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan

NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan

301 - 302